Last reviewed · How we verify
Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma
The purpose of this study is to evaluate the efficacy and safety of mRNA vaccine for HBV-positive Advanced Hepatocellular Carcinoma.
Details
| Lead sponsor | West China Hospital |
|---|---|
| Phase | PHASE1 |
| Status | UNKNOWN |
| Enrolment | 9 |
| Start date | Wed Feb 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Jan 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Liver Cancer
- Hepatocellular Carcinoma
Interventions
- HBV mRNA vaccine
Countries
China